Pdt Partners, LLC Codexis, Inc. Transaction History

Pdt Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $282,173 - $453,067	66,238 Added 277.82%	90,080 $419,000
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $144,482 - $306,608	23,842 New	23,842 $144,000
Q1 2022 May 16, 2022	SELL	$16.97 - $31.93 $1.18 Million - $2.22 Million	-69,513 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$25.61 - $41.78 $132,762 - $216,587	-5,184 Reduced 6.94%	69,513 $2.17 Million
Q3 2021 Nov 15, 2021	SELL	$19.65 - $27.99 $491,249 - $699,750	-25,000 Reduced 25.08%	74,697 $1.74 Million
Q2 2021 Aug 16, 2021	BUY	$17.48 - $25.46 $157,757 - $229,776	9,025 Added 9.95%	99,697 $2.26 Million
Q1 2021 May 17, 2021	BUY	$18.08 - $28.8 $635,566 - $1.01 Million	35,153 Added 63.32%	90,672 $2.08 Million
Q4 2020 Feb 16, 2021	BUY	$11.7 - $23.41 $145,126 - $290,377	12,404 Added 28.77%	55,519 $1.21 Million
Q3 2020 Nov 16, 2020	BUY	$11.21 - $13.82 $25,009 - $30,832	2,231 Added 5.46%	43,115 $506,000
Q2 2020 Aug 14, 2020	BUY	$9.8 - $12.77 $400,663 - $522,088	40,884 New	40,884 $466,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.